Articles tagged with Hematopoiesis
Researchers discover cancer-driving genes in microglia of Alzheimer's patients, suggesting a link between blood cancers and the neurodegenerative disease. The findings could lead to new diagnostic tools and therapeutic options for Alzheimer's.
Researchers found that patients with clonal hematopoiesis of indeterminate potential (CHIP) had a significantly higher incidence of heart failure and ischemic cardiovascular disease after cancer treatment. CHIP, a condition characterized by age-related variants in blood stem cells, puts patients at increased risk for heart complications.
Researchers develop ex vivo treatment of blood stem cells with Rhosin, a RhoA inhibitor, to rejuvenate them and improve the production of healthy blood cells. This strategy targets the core of the ageing process, making blood stem cells more capable of regenerating and producing new healthy blood cells.
Brazilian researchers analyzed over 60 scientific articles on microplastics and their impact on bone health. They found that the materials can impair bone marrow stem cells, accelerate cell aging, and promote inflammation, leading to potential bone weakening and fractures.
The study found that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL). Researchers identified a 'multipotency score' to predict clinical outcomes, providing valuable insights into drug resistance and str...
A study reveals that metal-organic frameworks (MOFs) can be toxic to mice, causing disruptions in blood cell formation and immune balance. The researchers found that the MOFs suppressed production of certain cells but also triggered a rebound effect, leading to increased inflammation.
Nancy A. Speck has been recognized for her groundbreaking research on hematopoiesis and leukemogenesis, with a focus on the transcription factor complex core binding factor. Her work has provided critical knowledge to understand how certain blood cancers develop, leading to significant insights in embryonic blood cell formation.
Researchers found that inhibiting WNT signaling after the hemogenic endothelium stage enhances blood progenitor formation from pluripotent stem cells. This strategy corrects intrinsic deficiencies and brings in vitro-derived HSPCs closer to their in vivo counterparts.
A new study found that mesenchymal stem cell-derived extracellular vesicles significantly enhance survival and facilitate substantial peripheral blood recovery in mice exposed to high-dose irradiation. The treatment promoted hematopoietic recovery, with increases in red blood cell, platelet, white blood cell, and hemoglobin levels.
Scientists have discovered how a mutated ASXL1 gene disrupts normal blood cell development, leading to diseases such as clonal hematopoiesis and malignant leukemias. The study reveals that mutated ASXL1 causes heterochromatin dysfunction, silencing genes essential for blood cell maturation.
Researchers developed a novel lentivirus-based gene therapy strategy in CD34+ hematopoietic progenitor cells, which showed therapeutic levels of expression of the anti-sickling beta globin protein. Cyclosporin improved transduction efficiency and preserved cell viability.
BEMOSAIC and MakingBlood projects aim to revolutionize vascular function and blood stem cell production, respectively. The ERC Synergy Grants will support the development of novel therapies for vascular-related pathologies and blood cancer patients.
Researchers suggest that hematopoietic stem and progenitor cells in the AML niche may retain an inflammatory memory, potentially leading to long-term functional consequences. This finding has significant implications for understanding the biology of acute myeloid leukemia (AML) and developing new cancer therapies.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
This study confirms the immune-boosting effects of ribonucleic acid for injection II, which promotes hematopoietic cell development by influencing gut microbiota and serum metabolites. Macrophage M1 differentiation plays a crucial role in this process.
A new study published in GEN Biotechnology describes the establishment of a 3D hydrogel-based platform for producing functional T-cells from hematopoietic stem and progenitor cells. The platform was engineered with key thymic components to direct T-cell development, producing cytokine-producing T-cells.
Scientists have discovered 17 new genes involved in clonal haematopoiesis, a process associated with ageing linked to increased risks of blood cancers. The findings highlight the clinical significance of these genes in driving mutant blood cell clones, offering new avenues for studying disease development and promoting healthier ageing.
Researchers discovered MIA-602's effectiveness against Doxorubicin-resistant acute myeloid leukemia (AML), demonstrating reduced cell viability and tumor volume. The study suggests MIA-602 as a potential alternative treatment approach for AML, potentially circumventing chemotherapy side effects.
Researchers highlight the role of post-transcriptional RNA modifications in AML pathogenesis, identifying m6A and m7G regulators as potential therapeutic targets. Targeted therapies, including selective inhibitors and Traditional Chinese Medicine compounds, show promise in promoting cell differentiation and reversing AML phenotypes.
Researchers discuss clonal hematopoiesis, a condition where cells harbor somatic mutations, and its association with aging, solid tumors, and treatment outcomes. Emerging evidence suggests that CH may play a role in cancer development and survival.
A comprehensive study found clonal hematopoiesis is prevalent in the elderly, associated with increased risk of hematological neoplasia and mortality. Smoking accelerates its development, while genetic variants predispose individuals to the condition.
A team of researchers at Tokyo Medical and Dental University has identified a gene called Rasip1 as crucial for blood cell development. SOX17, a transcription factor, is found to activate Rasip1, leading to the formation of hematopoietic stem cells and associated hematopoietic activity.
A new database linking RNA editing to blood cell differentiation has been established, providing a platform to accelerate research on leukemia and other pathologies. The REDH database includes detailed information on RNA editing sites in healthy and malignant hematopoietic cells.
Researchers from Tokyo Medical and Dental University have identified a previously unknown intermediate cell type, pre-basophils, which plays a critical role in the differentiation of precursor cells into mature basophils. These newly discovered cells exhibit higher proliferation capacity and distinct surface protein expression profiles...
Researchers at Indiana University School of Medicine discovered a strong association between obesity and clonal hematopoiesis of indeterminate potential (CHIP), a blood condition that increases the risk of blood cancer. The study found that obesity causes inflammation, which can lead to rapid growth of mutated blood cells.
Researchers developed a new clinical tool to predict clonal hematopoiesis (CH) risk in patients, using genetic data and demographic parameters. The tool assigns a score, defining three groups of patients with varying levels of cancer progression risk.
A new subset of B lymphocytes has been found to play a crucial role in promoting the clearance of microbes by enhancing the production of innate immune cells. The discovery highlights the importance of adaptive immune cells in responding to infections and could lead to new strategies for combating serious diseases.
Researchers found associations between cancer treatments and accumulated mutations in blood cells, a sign of accelerated aging called clonal hematopoiesis. This accumulation increases the risk of blood cancer and death in long-term childhood cancer survivors.
Leif Ludwig's analytical method allows for easier disentanglement of blood cell trajectories, enabling identification of leukemia cell development or degenerative changes. This breakthrough opens up possibility for human medicine to conduct studies in clinical practice and derive therapeutic interventions.
Researchers identified 17 clusters of single cells in peripheral blood, showing upregulation of antigen processing and presentation pathways and downregulation of genes involved in ribosome pathways with age. The study also found senescent T cells resistant to apoptosis, potentially targeted for treatment.
Researchers from Kumamoto University reveal how hematopoietic stem and progenitor cells orchestrate intestinal tissue repair through microbial signals. The study found that acute gut inflammation triggers the activation and expansion of immune progenitor cells, which migrate to lymph nodes to promote tissue repair.
Researchers have characterized the functional significance of DDX41 in molecular processes underlying cancer. The study reveals that DDX41 serves crucial functions in transcriptional processes, RNA splicing, and genomic integrity maintenance, which may hold significance in treating hematopoietic malignancies.
A high-fat diet in pregnant monkeys alters the transcriptional landscape of fetal blood stem cells, leading to a hyperinflammatory response and suppressed B-cell development. The study's findings suggest that maternal obesity may influence fetal bone marrow and immune system development.
Researchers found that liquid biopsies can detect clonal haematopoiesis, a condition placing patients at higher risk of developing myelodysplastic syndrome or acute myeloid leukaemia. The study suggests that these patients should be referred for further evaluation to uncover actual risk and identify potential diagnostic pathways.
Researchers discovered that macrophages eliminate stressed stem cells with high levels of reactive oxygen species, while healthy cells are amplified. The study found that a specific marker, calreticulin, acts as an 'eat me' signal for stressed cells.
Research at Kumamoto University reveals that fetal liver blood cells are stem cell-independent, contrary to the long-held view that HSCs are essential for their production. The study provides new insights into the origin of HSCs and suggests a reconsideration of their role in embryo formation.
Researchers at UNSW Sydney have made significant discoveries about embryonic blood stem cell creation that could one day eliminate the need for blood stem cell donors. Two studies have emerged from UNSW researchers in this area that shine new light on how precursors to blood stem cells occur in animals and humans, and how they may be i...
A study of NASA astronauts found DNA mutations associated with spaceflight, increasing the risk of cardiovascular disease and blood cancer. Regular screening is recommended to monitor astronaut health.
Researchers have identified a potential new therapeutic approach for angioimmunoblastic T-cell lymphoma (AITL) by understanding the mechanism of its development. A team from the University of Tsukuba found that B cells accumulate mutations in genes controlling genetic material packaging, leading to AITL.
Scientists at IRB Barcelona develop a new approach to pinpointing the genes driving clonal hematopoiesis, a biological process linked to ageing and increased risk of blood malignancies. By adapting cancer genomics tools, researchers aim to improve early detection and monitoring of this condition.
A study published in Annals of Internal Medicine found that Medicare could save up to $3.6 billion by purchasing generic drugs at the same prices as the Mark Cuban Cost Plus Drug Company. The researchers compared the price of 89 generic drugs sold by MCCPDC to the price Medicare paid in 2020 and estimated potential savings of up to $3....
A groundbreaking study using cellular barcoding in mice reveals that blood cells originate from two independent sources: hematopoietic stem cells and embryonic multipotent progenitor cells. These findings have significant implications for understanding blood cancers, bone marrow transplant, and the aging immune system.
The study found that mice lacking both Runx1 and Runx2 in CAR cells showed a significant reduction of HSPCs and immune cells, along with an increase in fibrosis. The researchers suggest that Runx1 and Runx2 may be potential targets for the diagnosis and treatment of myelofibrosis.
Researchers discovered how genetic mutations hijack blood cell production over a lifetime, leading to age-related diseases. The study tracked nearly 700 blood cell clones from 385 individuals aged over 55, revealing how age-dependent clonal behaviors mirror the frequency of emergence of different types of blood cancers.
A study led by Kobe University researchers found that idiopathic autism is caused by epigenetic abnormalities in hematopoietic cells, leading to immune dysregulation and brain-gut axis disorders. The study used BTBR mice as a model and identified histone deacetylase HDAC1 as a common mechanism underlying these pathologies.
Dr. John E. Dick will receive the inaugural AACR Award for Outstanding Achievement in Blood Cancer Research for his groundbreaking discoveries on leukemic stem cells and their mechanisms. His research has provided crucial insights into leukemia progression, survival rates, and treatment response.
An international research team discovered a new rare disease caused by a disrupted Helios-dependent epigenetic regulation mechanism, leading to T and B cell defects. The study highlights the importance of Helios in immune homeostasis and suggests potential therapeutic targets for immunodeficiency and malignancy.
A study suggests that suppressing the protective mechanisms of rogue blood stem cells can help curb clonal hematopoiesis and prevent leukemia. The researchers used zebrafish with colored 'barcodes' to track the dominance of cancerous clones, revealing a connection between anti-inflammatory genes and resistance to inflammation.
A study reveals that secreted cell factors, particularly TGFβ1, inhibit hematopoiesis in humans with acute myeloid leukemia. Blocking TGFβ1 could improve hematopoiesis in AML patients.
A study published in JACC reveals that clonal hematopoiesis, a phenomenon where acquired DNA mutations accelerate heart failure progression, is an independent risk factor. The presence of specific mutant clones, including those with TET2 and DNMT3A mutations, increases the risk of hospitalization and death from heart failure.
Researchers found that a point mutation in the zebrafish slc20a1b gene significantly reduces the proliferation of hematopoietic stem/progenitor cells, resulting in a severe defect of hematopoietic development. The study reveals the indispensable role of slc20a1b in HSPCs, highlighting a novel regulation gene for cell cycle expansion.
Researchers found that anti-inflammatory therapies could be effective in preventing heart disease in people with clonal hematopoiesis, a common age-related blood condition. The study suggests that targeting the inflammasome may reduce cardiovascular risk and improve plaque stability.
Researchers at Massachusetts General Hospital found that atherosclerosis can accelerate the development of clonal hematopoiesis. Clonal hematopoiesis is an age-related condition where descendants of one hematopoietic stem cell dominate blood cells.
A recent study by Dana-Farber Cancer Institute scientists has found that clonal hematopoiesis can confer a health benefit in the setting of allogeneic stem cell or bone marrow transplants. Patients who received transplants from older donors with CH had a lower risk of relapse and longer survival compared to those without CH.
Researchers found that RNA from repetitive elements activates RIG-I-like receptors, inducing inflammation and increasing hematopoietic stem cell numbers. The RIG-I-like receptor family plays a crucial role in regulating hematopoiesis, with different members having opposing effects on developmental hematopoiesis.
Women with premature menopause are at higher risk of developing coronary artery disease due to the presence of clonal hematopoiesis in their blood cells. The study found a 36% increased likelihood of clonal hematopoiesis and a 48% higher risk of coronary artery disease among women with premature menopause.
Researchers from NUS identified covalently closed circular RNAs (circRNAs) from the ASXL1 gene involved in leukemia development and found that circASXL1-1 regulates BAP1 deubiquitinase activity. The study provides insights into a new mechanism for H2AK119ub levels regulation, which could lead to targeted therapeutic approaches.
Researchers at Hackensack Meridian Health's CDI laboratory have made a breakthrough in treating blood cancers, specifically leukemia. They identified a novel protein called Stem Cell Growth Factor Alpha (SCGFa), which has shown promise in preserving vascular function and promoting hematopoietic recovery following chemotherapy.
Researchers have made significant progress in generating functional hematopoietic stem cells from human pluripotent stem cells. Key findings include the role of transcription factors HOX and GATA proteins in regulating hematopoiesis, which may lead to breakthroughs in treating blood cancers and other disorders.
Researchers at Pohang University of Science & Technology discovered a mechanism by which microbiota signals are transmitted to the entire body, controlling hematopoiesis in the bone marrow. This process involves CX3CR1+ mononuclear cells recognizing microbiota signals and releasing cytokines that stimulate the immune system.